# Effect of Iron on Cerebral Dopamine Receptor Density in Non-anaemic Premenopausal Women With Low Ferritin and Fatigue

> **NCT03305705** · PHASE4 · UNKNOWN · sponsor: **Albina Nowak, MD** · enrollment: 20 (estimated)

## Conditions studied

- Fatigue
- Iron-deficiency

## Interventions

- **DRUG:** Iron Carboxymaltose
- **DRUG:** Sodium chloride 0.9%

## Key facts

- **NCT ID:** NCT03305705
- **Lead sponsor:** Albina Nowak, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-23
- **Primary completion:** 2019-08-31
- **Final completion:** 2019-08-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03305705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03305705, "Effect of Iron on Cerebral Dopamine Receptor Density in Non-anaemic Premenopausal Women With Low Ferritin and Fatigue". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03305705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*